White Papers and eBooks

Whitepaper: Join InStep Health as They Discuss Finding Success During the Pandemic

Since the Pandemic Began.. The phrase "uncertain times" has frequently been used to describe our shared sense of confusion, fear, and anxiety regarding COVID-19. During this period we have become accustomed to the disproportionate weight of having more questions than answers. At second glance, through applied quantitative measurements, marketers may...


White Paper: CMO’s Dilemma: What Will Be the “New Normal”?

It remains no secret that Pharma marketing is in a state of flux, precipitated by the COVID-19 pandemic. Virtual Channels, Promotion and Messaging are the Only Option Now. With this as a backdrop, the graphic below serves as an introductory glimpse into the latest edition of SRI’s  Virtual Viewpoint: CMO’s Dilemma: What Will Be the “New Normal”,...


White Paper: 10 essentials every pharma marketer must utilize when emailing physicians

Social distancing and quarantine have only reinforced what many marketers already know: email is king. It yields 50% savings compared to print marketing, and can boast average open rates of over 13% while allowing for tracking on an individual level. But crafting emails to healthcare practitioners (HCPs) is less a science than an art. And HCPs are always...


Whitepaper: Revolution, Evolution Or Agile Solution

How will pharma engage with customers in a post-COVID-19 world? In this whitepaper, we look at how the pharma industry is communicating with healthcare professionals and assess what the future holds for the pharma commercial interaction model. As with so many sectors, the coronavirus pandemic has had a profound impact on the healthcare industry. Currently...


Are We Missing the Magic?

What Behavioral Science can tell us about communications research  Is traditional advertising’s concept-testing research working as well as it could? Is it time to rethink our approach? This white paper explores how behavioral science can uncover the flaws of traditional communications research and offer an advanced, alternative approach to harnessing...


White Paper: Why precision therapies require a precision approach to marketing

Explore how to target specialized providers when and where they’re most likely to engage. Learn the keys to effective marketing campaigns that can cut through the messaging clutter, address unmet physician needs and serve as a key component to the commercial success of precision therapies. Commentary from Eli Phillips, Jr. (Vice President, Regulatory...


Influence and Inspire Action: Performance-Driven Medical Education

Every interaction matters: Promotional medical education that influences and inspires action Pharma companies are missing valuable opportunities with physicians. Did you know that 80% of the content provided by pharmaceutical companies is not what healthcare professionals (HCPs) want? Provider interactions are not being maximized. Promotional medical...


White Paper: 10+ Benefits of Moving Your Advisory Boards Online

In today’s ever-changing competitive landscape, staying one step ahead of the competition is more important than ever for Pharma brands. To this end, it is crucial to understand the needs and wants of all relevant stakeholders. Traditionally, this has been achieved through in-person advisory boards. However, with shrinking budgets and increasing numbers...


White Paper: Challenges In Thought Leader Management

Data Analytics And Technology Can Help The pharmaceutical industry has been reshaped by many changes over the past decade, including the emergent power of managed care, the declining use of sales representatives, and the explosive growth of data and digital platforms as marketing tools. One key aspect of the business that has remained constant,...


Patient Experience in Clinical Trials: Survey results reveal that an outdated perception of what patients think about clinical trials may be holding you back

Is an outdated perception of what patients think about clinical trials holding you back? A recent survey of 244 clinical trial participants, conducted by Health Union, uncovered that patients who have engaged in clinical trials more recently, since 2013 vs. before 2013, were more satisfied with their experience and had a greater willingness to participate...